Patents by Inventor Hans Albertson

Hans Albertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic markers associated with endometriosis and use thereof
    Patent number: 11287425
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Grant
    Filed: April 22, 2010
    Date of Patent: March 29, 2022
    Assignee: Juneau Biosciences, LLC
    Inventors: Kenneth Ward, Hans Albertson
  • Genetic Markers Associated with Endometriosis and Use Thereof
    Publication number: 20150361494
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 17, 2015
    Applicant: JUNEAU BIOSCIENCES, LLC
    Inventors: Kenneth Ward, Hans Albertson, Georges C. Frech, Rakesh N. Chettier
  • APC gene and nucleic acid probes derived therefrom
    Patent number: RE36713
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in hum tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as wel as in sporadic colorectal cancer patents. APC is expressed in most normal tissue. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: May 23, 2000
    Assignees: The Johns Hopkins University, The University of Utah, Zeneca, Cancer Institute
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Hans Albertson, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Alexander Fred Markham, Yusuke Nakamura, Andrew Thliveris, Raymond White